Market Overview:
The global secondary antibody market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for secondary antibodies for research and diagnostic applications. Additionally, the growing prevalence of diseases is also contributing to the growth of this market. On the basis of type, IgG antibodies are expected to account for the largest share of the global secondary antibody market in 2018. This can be attributed to their high specificity and affinity towards antigens.
Product Definition:
A secondary antibody is an immunoglobulin molecule that specifically binds to an antigen on a primary antibody. The secondary antibody can be from the same species as the primary, or a different species. Secondary antibodies are used in many applications, including ELISA and Western blotting. They can also be used to label cells or tissues for microscopy or flow cytometry.
IgG:
IgG is the first type of antibody produced by plasma cells and B-lymphocytes in response to an antigen. It is also known as immunoglobulin G, or just IgG. The primary function of IgG is to enable the immune system to recognize and attack cancerous cells.
IgM:
IgM is the first type of antibody that is produced by plasma cells and B-lymphocytes. It accounts for about 70% of the total immunoglobulin in blood. The other types are IgD, IgE, and IgK which are found in highest concentration in serum.
Application Insights:
The hospital application segment led the global secondary antibody market in 2017. The segment is projected to expand further at a steady growth rate over the forecast period owing to rising incidences of infectious diseases, an increasing number of surgeries and high patient admissions in hospitals. In addition, factors such as growing healthcare spending by governments as well as private players coupled with technological advancements are expected to drive the hospital application segment during the forecast period.
The life sciences sector accounted for a significant share in 2017 and is anticipated to grow at a CAGR exceeding 11% from 2018 to 2030 due mainly to increasing R&D activities pertaining antibodies for disease diagnosis and drug development. Moreover, new product launches coupled with technological advancements are also expected fuel industry growth over the coming years.
Regional Analysis:
North America dominated the global secondary antibody market in 2017. The presence of well-established healthcare infrastructure, high adoption rate of new technologies, and high disease burden are some factors responsible for its large share. Moreover, increasing government initiatives to develop novel diagnostic approaches is also expected to drive the regional market over the forecast period. For instance, in March 2018, a collaboration was announced by UAB and Pfizer Inc., wherein UAB would provide access to its COVID-19 monoclonal antibodies through Pfizer’s Ovidrel biologics program for emergency contraception pill (ECP) formulation.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising investments by major players in this region along with growing awareness about advanced therapeutics among patients suffering from chronic diseases such as cancer and diabetes.
Growth Factors:
- Increasing demand for monoclonal antibodies in research and development activities
- Rising prevalence of chronic diseases that require regular monitoring and treatment
- Growing number of biotechnology and pharmaceutical companies investing in the development of novel therapies
- Proliferation of targeted cancer therapies that require specific antibodies for treatment
- Technological advancements in antibody-based detection methods
Scope Of The Report
Report Attributes
Report Details
Report Title
Secondary Antibody Market Research Report
By Type
IgG, IgM, IgA, IgE, IgD
By Application
Hospital, Life Sciences, Laboratory
By Companies
Biorbyt, Bio-Rad, SouthernBiotech, Thermo Fisher Scientific, Miltenyi Biotec, Abcam, Novus Biologicals, Bio-Techne, Rockland Immunochemicals, Proteintech, Genscript Biotech, Boster Bio, Advansta Inc, Creative Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
215
Number of Tables & Figures
151
Customization Available
Yes, the report can be customized as per your need.
Global Secondary Antibody Market Report Segments:
The global Secondary Antibody market is segmented on the basis of:
Types
IgG, IgM, IgA, IgE, IgD
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Life Sciences, Laboratory
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Biorbyt
- Bio-Rad
- SouthernBiotech
- Thermo Fisher Scientific
- Miltenyi Biotec
- Abcam
- Novus Biologicals
- Bio-Techne
- Rockland Immunochemicals
- Proteintech
- Genscript Biotech
- Boster Bio
- Advansta Inc
- Creative Diagnostics
Highlights of The Secondary Antibody Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- IgG
- IgM
- IgA
- IgE
- IgD
- By Application:
- Hospital
- Life Sciences
- Laboratory
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Secondary Antibody Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Secondary antibody is a type of antibody that is made in response to an antigen that has already been identified and isolated. Secondary antibodies are used to detect and identify specific antigens.
Some of the major players in the secondary antibody market are Biorbyt, Bio-Rad, SouthernBiotech, Thermo Fisher Scientific, Miltenyi Biotec, Abcam, Novus Biologicals, Bio-Techne, Rockland Immunochemicals, Proteintech, Genscript Biotech, Boster Bio, Advansta Inc, Creative Diagnostics.
The secondary antibody market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Secondary Antibody Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Secondary Antibody Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Secondary Antibody Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Secondary Antibody Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Secondary Antibody Market Size & Forecast, 2020-2028
4.5.1 Secondary Antibody Market Size and Y-o-Y Growth
4.5.2 Secondary Antibody Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 IgG
5.2.2 IgM
5.2.3 IgA
5.2.4 IgE
5.2.5 IgD
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Life Sciences
6.2.3 Laboratory
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Secondary Antibody Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Secondary Antibody Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 IgG
9.6.2 IgM
9.6.3 IgA
9.6.4 IgE
9.6.5 IgD
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Life Sciences
9.10.3 Laboratory
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 IgG
10.6.2 IgM
10.6.3 IgA
10.6.4 IgE
10.6.5 IgD
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Life Sciences
10.10.3 Laboratory
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 IgG
11.6.2 IgM
11.6.3 IgA
11.6.4 IgE
11.6.5 IgD
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Life Sciences
11.10.3 Laboratory
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 IgG
12.6.2 IgM
12.6.3 IgA
12.6.4 IgE
12.6.5 IgD
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Life Sciences
12.10.3 Laboratory
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 IgG
13.6.2 IgM
13.6.3 IgA
13.6.4 IgE
13.6.5 IgD
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Life Sciences
13.10.3 Laboratory
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Secondary Antibody Market: Competitive Dashboard
14.2 Global Secondary Antibody Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Biorbyt
14.3.2 Bio-Rad
14.3.3 SouthernBiotech
14.3.4 Thermo Fisher Scientific
14.3.5 Miltenyi Biotec
14.3.6 Abcam
14.3.7 Novus Biologicals
14.3.8 Bio-Techne
14.3.9 Rockland Immunochemicals
14.3.10 Proteintech
14.3.11 Genscript Biotech
14.3.12 Boster Bio
14.3.13 Advansta Inc
14.3.14 Creative Diagnostics
